Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands. (Record no. 18663132)

MARC details
000 -LEADER
fixed length control field 01671 a2200481 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515160722.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1520-4804
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1021/jm8000983
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Gümüş, Fatma
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100629
245 00 - TITLE STATEMENT
Title Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of medicinal chemistry
Date of publication, distribution, etc. Mar 2009
300 ## - PHYSICAL DESCRIPTION
Extent 1345-57 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision chemical synthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzimidazoles
General subdivision chemical synthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Cycle
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element DNA
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Screening Assays, Antitumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydrophobic and Hydrophilic Interactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ligands
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Structure
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nucleic Acid Conformation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Plasmids
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Structure-Activity Relationship
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eren, Gökçen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Açik, Leyla
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Celebi, Ayten
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Oztürk, Fatma
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yilmaz, Sükran
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sagkan, Rahşan Ilikçi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gür, Sibel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ozkul, Aykut
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Elmali, Ayhan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Elerman, Yalçin
773 0# - HOST ITEM ENTRY
Title Journal of medicinal chemistry
Related parts vol. 52
-- no. 5
-- p. 1345-57
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1021/jm8000983">https://doi.org/10.1021/jm8000983</a>
Public note Available from publisher's website

No items available.